Nexalin Technology, Inc. Common Stock
NXL
NXL: Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy.
moreShow NXL Financials
Recent trades of NXL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NXL's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on NXL's company Twitter account
Number of mentions of NXL in WallStreetBets Daily Discussion
Recent insights relating to NXL
Recent picks made for NXL stock on CNBC
ETFs with the largest estimated holdings in NXL
Flights by private jets registered to NXL